
Reviewer to the NCI SBIR for Novel Imaging Agents, the Innovative Medicines Initiative (IMI), the Swedish foundation for Strategic Research, the Society of Nuclear Medicine for Oncology – Basic Science track and serving as a peered journal's reviewer on topics of molecular imaging, radiopharmaceuticals and apoptosis/angiogenesis imaging
- Consulting for drug and imaging agents from Discovery and Development to Commercialization
- Successfully completed all requirements for the I-Corps @ NIH Program (June-August 2016)